Other preliminary proxy statements



>


















Schedule 14A








Schedule 14A Information










Proxy Statement Pursuant to Section 14(a) of the




Securities Exchange Act of 1934


































































Filed by the Registrant


þ





Filed by a party other than the Registrant


¨




















Check the appropriate box:















þ





Preliminary Proxy Statement





¨





Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))





¨





Definitive Proxy Statement – 2020 Annual Meeting of Stockholders





¨





Definitive Additional Materials





¨





Soliciting Material Pursuant to § 240.14a-12




































































































































NATURAL HEALTH TRENDS CORP.





(Name of Registrant as Specified In Its Charter)










(Name of Person(s) Filing Proxy Statement, if other than the Registrant)










Payment of Filing Fee (Check the appropriate box):





þ










No fee required





¨










Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.















(1)










Title of each class of securities to which transaction applies:















(2)










Aggregate number of securities to which transaction applies:















(3)










Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):















(4)










Proposed maximum aggregate value of transaction:















(5)










Total fee paid:





¨










Fee paid previously with preliminary materials.





¨










Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.















(1)










Amount Previously Paid:















(2)










Form, Schedule or Registration Statement No.:















(3)










Filing Party:















(4)










Date Filed:


























NATURAL HEALTH TRENDS CORP.










NOTICE OF ANNUAL MEETING OF STOCKHOLDERS




TO BE HELD ON


MAY 14, 2020










To the Stockholders of Natural Health Trends Corp.:








The 2020 annual meeting of stockholders of Natural Health Trends Corp. (the “Company”) will be held on


May 14, 2020


, beginning at 9:00 a.m. local time, at The Ritz-Carlton, Rancho Mirage, 68900 Frank Sinatra Drive, Rancho Mirage, CA 92270. At the meeting, the holders of the Company’s outstanding common stock will act on the following matters:


























Election of five (5) directors to the Board of Directors of the Company to serve until the next annual meeting of the Company’s stockholders























Ratification of the appointment of Marcum LLP as independent registered public accounting firm for the Company for fiscal year ending


December 31, 2020























Approval and adoption of the amendment to the Company’s certificate of incorporation to provide that directors are removable with or without cause











All holders of record of shares of the Company’s common stock at the close of business on


March 18, 2020


are entitled to vote at the meeting and any postponements or adjournments of the meeting.










We are using Securities and Exchange Commission rules that allow the Company to furnish proxy materials on the Internet to stockholders of the Company. Consequently, stockholders will not automatically receive paper copies of our proxy materials. We are instead sending to stockholders a Notice of Internet Availability of Proxy Materials with instructions for accessing the proxy materials, including our proxy statement and Annual Report on Form 10-K, and for voting via the Internet. The electronic delivery of our proxy materials will reduce our printing and mailing costs and any environmental impact.








The Notice of Internet Availability of Proxy Materials identifies the date, time and location of the annual meeting; the matters to be acted upon at the meeting and the Board of Directors’ recommendation with regard to each matter; a toll-free telephone number, an e-mail address, and a website where shareholders can request a paper or e-mail copy of our proxy materials, including our Annual Report on Form 10-K, proxy statement and a proxy card, free of charge.










We currently intend to hold our annual meeting in person. However, we are monitoring the coronavirus (COVID-19) outbreak and related precautions, and it may become necessary or advisable to change the date, time, location and/or means of holding the annual meeting (including by means of remote communication). Any such change will be announced via press release and website posting, as well as the filing of additional proxy materials with the Securities and Exchange Commission.



































By Order Of The Board Of Directors,
















/s/ Timothy S. Davidson





April 2, 2020





Timothy S. Davidson


Chief Financial Officer,


Senior Vice President


and Corporate Secretary











WHETHER OR NOT YOU EXPECT TO BE PRESENT AT THE MEETING, PLEASE EXERCISE YOUR VOTING RIGHTS. THE PROXY STATEMENT IS FIRST BEING SENT OR GIVEN TO THE COMPANY’S STOCKHOLDERS ON OR ABOUT APRIL 2, 2020.





























TABLE OF CONTENTS



































































































































































































Page





ABOUT THE MEETING







What is the purpose of the meeting?







Who is entitled to vote at the meeting?







What are the voting rights of the holders of the Company’s common stock?







Who can attend the meeting and where is it being held?







Why did I initially receive a Notice of Internet Availability regarding proxy materials instead of a full set of proxy materials?







How can I elect the manner in which I will receive proxy materials in the future?







How do I vote?







How may my broker, bank or other agent vote my shares if I fail to provide timely directions?







Can I change my vote or revoke my proxy?







What constitutes a quorum?







What are the Board of Directors’ recommendations?







What vote is required to approve each item?







What types of expenses will the Company incur?

















STOCK OWNERSHIP







Who are the owners of the Company’s stock?







Were there any delinquent Section 16(a) reports during 2019?























GOVERNANCE OF THE COMPANY







Who are the current members of the Board of Directors and on which committees do they serve?







Who is the Chairman of the Board of Directors?







Which directors are considered independent?







How often did the Board of Directors meet during fiscal 2019?







What is the role of the Board of Directors’ Audit, Compensation and Nominating and Corporate Governance Committees?







What is the Board of Directors’ role in risk oversight?







How are directors compensated?







How do stockholders communicate with the Board of Directors?







Are Company employees or directors permitted to engage in hedging transactions?







Does the Company have a Code of Ethics?







Certain Relationships and Related Transactions—What related party transactions requiring disclosure involved directors, executive officers or significant stockholders?

















INFORMATION ABOUT EXECUTIVE OFFICERS

















REPORT OF THE AUDIT COMMITTEE

















EQUITY COMPENSATION PLAN INFORMATION

















COMPENSATION OF NAMED EXECUTIVE OFFICERS AND DIRECTORS







Summary Named Executive Officer Compensation Information







Named Executive Officer Compensation Arrangements

































































































































Outstanding Equity Awards at December 31, 2019







Severance and Post-Termination Payment Arrangements







Director Compensation

















ITEM ONE: ELECTION OF DIRECTORS







Biographical Summaries of Nominees for the Board of Directors

















ITEM TWO: RATIFICATION OF THE APPOINTMENT OF MARCUM LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE COMPANY FOR FISCAL YEAR ENDING DECEMBER 31, 2020







Audit and Other Professional Fees







Pre-approval Policies and Procedures for Audit and Non-Audit Services

















ITEM THREE: APPROVAL AND ADOPTION OF THE AMENDMENT TO THE COMPANY’S CERTIFICATE OF INCORPORATION TO PROVIDE THAT DIRECTORS ARE REMOVABLE WITH OR WITHOUT CAUSE







Introduction and Reasons for Amendment







Description of Amendment







Effects of Stockholder Approval of Proposed Amendment

















OTHER MATTERS

















ADDITIONAL INFORMATION







Stockholder Proposals for the 2021 Annual Meeting of Stockholders

















HOUSEHOLDING INFORMATION


































NATURAL HEALTH TRENDS CORP.










PROXY STATEMENT








This proxy statement contains information related to the annual meeting of stockholders of Natural Health Trends Corp. (“the Company”) to be held on


May 14, 2020


beginning at 9:00 a.m. local time, at The Ritz-Carlton, Rancho Mirage, 68900 Frank Sinatra Drive, Rancho Mirage, CA 92270, and at any postponements or adjournments thereof. This proxy statement is first being made available to stockholders on or about April 2, 2020.

















ABOUT THE MEETING








What is the purpose of the meeting?








At the annual meeting, stockholders will act upon the matters outlined in the Notice of Annual Meeting of Stockholders included with this proxy statement.









Who is entitled to vote at the meeting?








Only stockholders of record at the close of business on


March 18, 2020


, the record date for the meeting, are entitled to receive notice of and to participate in the annual meeting. If you were a stockholder of record on that date, you will be entitled to vote all of the shares that you held on that date at the meeting, or any postponements or adjournments of the meeting.











What are the voting rights of the holders of the Company’s common stock?








Each outstanding share of the Company’s common stock will be entitled to one vote on each matter considered at the meeting. Cumulative voting in the election of directors is prohibited by the Company’s certificate of incorporation.









Who can attend the meeting and where is it being held?








All stockholders as of the record date, or their duly appointed proxies, may attend the meeting. The meeting is being held at the location identified above. To obtain directions to attend the meeting in person, please contact the Company at +852-3107-0800.










We currently intend to hold our annual meeting in person. However, we are monitoring the coronavirus (COVID-19) outbreak and related precautions, and it may become necessary or advisable to change the date, time, location and/or means of holding the annual meeting (including by means of remote communication). Any such change will be announced via press release and website posting, as well as the filing of additional proxy materials with the Securities and Exchange Commission.











Why did I initially receive a Notice of Internet Availability regarding proxy materials instead of a full set of proxy materials?










Pursuant to rules adopted by the Securities and Exchange Commission, we have elected to provide access to our proxy materials over the Internet to our stockholders. Accordingly, a Notice of Internet Availability of Proxy Materials (“Notice of Internet Availability”) was or will be sent to many of our stockholders providing notice of the annual meeting and enabling stockholders to access our proxy materials on the website referred to in the Notice of Internet Availability or request to receive free of charge a printed set of the proxy materials, including the Notice of Annual Meeting, our 2019 Annual Report on Form 10-K, this proxy statement and a proxy card. Instructions on how to access the proxy materials over the Internet or to request a printed copy are set out in the Notice of Internet Availability. Those stockholders that previously requested to receive our proxy materials in printed or electronic form will receive such proxy materials in lieu of the Notice of Internet Availability.











How can I elect the manner in which I will receive proxy materials in the future?










All stockholders may request to receive proxy materials in printed form by mail or electronically by e-mail on an ongoing basis by following the instructions in the Notice of Internet Availability or proxy materials. The Company encourages stockholders to take advantage of the availability of the proxy materials on the Internet in order to help reduce printing and mailing costs and any environmental impact.















1




















How do I vote?




























By Mail:





If you complete and properly sign the accompanying form of proxy card and return it to the indicated address, it will be voted as you direct.

























In Person:





If you are a registered stockholder and attend the meeting, you may vote in person at the meeting. If you are a beneficial owner of shares registered in the name of your broker, bank or other agent, you must obtain a valid legal proxy from your broker, bank or other agent to vote in person at the meeting.

























Via Internet:





Log on to


http://www.proxyvote.com


and follow the on-screen instructions.













Note:    Please also refer to the specific instructions set forth in the Notice of Internet Availability or, if you requested to receive our proxy materials in printed or electronic form, in the proxy materials.











How may my broker, bank or other agent vote my shares if I fail to provide timely directions?










Brokers, banks or other agents holding shares of common stock in street name for customers are generally required to vote such shares in the manner directed by their customers. In the absence of timely directions, your broker, bank or other agent will have discretion to vote your shares on the “routine” matters to be voted upon at the meeting — the proposal to ratify the appointment of Marcum LLP (Item Two) and the proposal to amend the Company’s certificate of incorporation (Item Three). Your broker may not have discretion to vote on the election of directors (Item One) absent direction from you.











Can I change my vote or revoke my proxy?








Yes. You can change your vote or revoke your proxy. If you are a registered stockholder, you may revoke your proxy in any one of four ways.


























You may send a written notice that you are revoking your proxy to the Company's Corporate Secretary at the Company’s principal executive offices located at Units 1205-07, 12F, Mira Place Tower A, 132 Nathan Road, Tsimshatsui, Kowloon, Hong Kong, Attention: Timothy S. Davidson.























You may timely grant another proxy via the Internet.























You may submit another properly completed proxy card with a later date.























You may attend the annual meeting and vote in person. Simply attending the annual meeting will not, by itself, revoke your proxy.











Your most current proxy, whether submitted by proxy card, via the Internet or in person, is the one that is counted.








If your shares are held by your broker, bank or other agent, you should follow the instructions provided by your broker, bank or other agent.









What constitutes a quorum?










The presence at the meeting, in person or by proxy, of the holders of a majority of the aggregate voting power of the stock outstanding on the record date will constitute a quorum, permitting the stockholders to act upon the matters outlined in the Notice of Annual Meeting of Stockholders. As of the record date, 11,422,539 shares of common stock, representing the same number of votes, were outstanding. Thus, the presence of the holders of common stock representing at least 5,711,270 shares of common stock will be required to establish a quorum.










A proxy submitted by a stockholder may indicate that all or a portion of the shares represented by the proxy are not being voted (“stockholder withholding”) with respect to a particular matter. Similarly, a broker may not be permitted to vote stock (“broker non-vote”) held in street name on a particular matter in the absence of instructions from the beneficial owner of the stock. See above under the caption “How may my broker, bank or other agent vote my shares if I fail to provide timely directions?” The shares subject to a proxy that are not being voted on a particular matter because of either stockholder withholding or broker non-vote will count for purposes of determining the presence of a quorum. Abstentions are also counted in the determination of a quorum.















2




















What are the Board of Directors’ recommendations?








Unless you give other instructions on your returned proxy, the persons named as proxy holders on the proxy will vote in accordance with the recommendations of the Board of Directors. The Board of Directors’ recommendations are set forth together with the description of each item in this proxy statement. In summary, the Board of Directors recommends a vote:




























for


election of the nominated slate of Directors (see Item One)























for


ratification of the appointment of Marcum LLP as independent registered public accounting firm for the Company for fiscal year ending December 31, 2020 (see Item Two)























for


approval and adoption of the amendment to the Company’s certificate of incorporation to provide that directors are removable with or without cause (see Item Three).











With respect to any other matter that properly comes before the meeting, the proxy holders will vote as recommended by the Board of Directors or, if no recommendation is given, in their own discretion.









What vote is required to approve each item?








Election of Directors.


The affirmative vote of a plurality of the votes of the shares present in person or represented by proxy and entitled to vote on the election of directors at the meeting (Item One). You may vote “for” or “withhold” on each of the nominees for election as a director. Any shares not voted “for” a particular nominee (whether as a result of “withhold” votes or broker non-votes) will not be counted in such nominee’s favor and will have no direct effect on the outcome of the election.










Ratification of Independent Registered Public Accounting Firm.


For the ratification of the appointment of Marcum LLP as independent registered public accounting firm for the Company for fiscal year ending December 31, 2020 (Item Two), the affirmative vote of a majority of the votes cast by the stockholders present in person or represented by proxy and entitled to vote at the meeting will be required for approval. You may vote “for,” “against” or “abstain” on this proposal. Abstentions and broker non-votes (to the extent applicable) are not considered “votes cast” on this item, and thus will not affect the outcome of the vote for this item.










Approval and Adoption of Amendment to the Company’s Certificate of Incorporation.


For the approval and adoption of the amendment to the Company’s certificate of incorporation to provide that directors are removable with or without cause (Item Three), the affirmative vote of the holders of two-thirds (2/3) of the outstanding shares of common stock will be required. You may vote “for,” “against” or “abstain” on this proposal. Abstentions and broker non-votes (to the extent applicable) will have the effect of negative votes for such proposal.











What types of expenses will the Company incur?








The expense of preparing, printing and mailing proxy materials and the Notice of Internet Availability, as well as all expenses of soliciting proxies, will be borne by the Company. In addition to the use of the mails, proxies may be solicited by officers and directors and regular employees of the Company, without additional remuneration, by personal interaction, telephone, telegraph or facsimile transmission. The Company may elect to engage a proxy solicitation firm to solicit stockholders to vote or grant a proxy with respect to the proposals contained in this proxy statement. The Company will request brokers, banks, nominees, custodians, fiduciaries and other agents to forward proxy materials to the beneficial owners of shares of common stock held of record and will provide reimbursements for the cost of forwarding the material in accordance with customary charges.









3




















STOCK OWNERSHIP











Who are the owners of the Company’s stock?








The following table shows the amount of the Company’s common stock beneficially owned (unless otherwise indicated) as of


March 18, 2020


by (i) each stockholder known to us to be the beneficial owner of more than 5% of the Company’s common stock, (ii) each director or director nominee, (iii) each of the Company’s named executive officers and (iv) all executive officers and directors as a group. Beneficial ownership is determined in accordance with the rules and regulations of the Securities and Exchange Commission and generally includes those persons who have voting or investment power with respect to the securities. Except as otherwise indicated, and subject to applicable community property laws, the persons named in the table have sole voting and investment power with respect to all shares of the Company’s common stock beneficially owned by them.


































































































































Name and Address of Beneficial Owner



(1)











Amount and Nature of Beneficial Ownership



(2)











Percent of




Class



(2)






Executive Officers and Directors:

























Chris T. Sharng










886,645












(3)





7.8





%





Timothy S. Davidson










391,100












(4)





3.4





%





George K. Broady










690,099












(5)





6.0





%





Yiu T. Chan









































Kin Y. Chung










3,058

















*












Randall A. Mason










252,733












(6)





2.2





%





All executive officers and directors as a group (6 persons)










2,223,635












(7)





19.5





%





Non-Executive Stockholders Beneficially Owning 5% or More

























The Jane Eleanor Broady Irrevocable Trust










2,245,128












(8)





19.7





%





Renaissance Technologies LLC










891,017












(9)





7.8





%





_______________________
































*





Less than 1% of the Company’s outstanding common stock.























(1)





Unless otherwise indicated, the address of each beneficial owner is c/o Natural Health Trends Corp., Units 1205-07, 12F, Mira Place Tower A, 132 Nathan Road, Tsimshatsui, Kowloon, Hong Kong.

















(2)





Any securities not outstanding that are subject to conversion privileges exercisable within 60 days of


March 18, 2020


are deemed outstanding for the purpose of computing the percentage of outstanding securities of the class owned by any person holding such securities, but are not deemed outstanding for the purpose of computing the percentage of the class owned by any other person in accordance with Item 403 of Regulation S-K promulgated under the Securities Exchange Act of 1934 (as amended, the “Exchange Act”) and Rules 13(d)-3 of the Exchange Act, and based upon 11,422,539 shares of common stock outstanding as of


March 18, 2020


.

















(3)





Includes 307,015 shares of restricted stock subject to vesting.

















(4)





Includes 119,493 shares of restricted stock subject to vesting.

















(5)





All shares of stock are held by the George K. Broady 2012 Irrevocable Trust, of which Mr. Broady is the trustee and a beneficiary. The George K. Broady 2012 Irrevocable Trust pledged 570,390 shares to secure a line of credit.

















(6)





Includes (i) 23,899 shares owned by Marden Rehabilitation Associates, Inc., an entity controlled by Mr. Mason.

















(7)





Includes 426,508 shares of restricted stock subject to vesting.

















(8)





Jane Eleanor Broady, the spouse of George K. Broady, is a beneficiary of The Jane Eleanor Broady 2012 Irrevocable Trust. The Jane Eleanor Broady 2012 Irrevocable Trust pledged 2,129,610 shares to secure a line of credit.

















(9)





The information regarding the beneficial ownership of Renaissance Technologies LLC (“RTC”) is based on the Schedule 13G filed jointly with Renaissance Technologies Holdings Corporation (“RTHC”) with the Securities and Exchange Commission on February 13, 2020. According to this Schedule 13G, RTHC owns a majority of RTC and therefore each of RTC and RTHC is deemed to have sole voting and dispositive power over all 891,017 common shares. The address for each of RTC and RTHC is 800 Third Avenue, New York, New York 10022.
















4




















Were there any delinquent Section 16(a) reports during 2019?










Section 16(a) of the Exchange Act requires the Company’s directors and executive officers, and persons who own more than ten percent (10%) of a registered class of the Company’s equity securities, to file with the Securities and Exchange Commission initial reports of ownership and reports of changes in ownership of common stock and other equity securities of the Company. To the Company’s knowledge, based solely on its review of electronic filings with the Securities and Exchange Commission and any written representations received by the Company from persons required to make filings under Section 16(a), all Section 16(a) filing requirements applicable to its officers, directors and greater than ten percent beneficial owners were satisfied.











GOVERNANCE OF THE COMPANY









Who are the current members of the Board of Directors and on which committees do they serve?








The members of the Board of Directors on the date of this proxy statement and the committees of the Board of Directors on which they serve are identified below.


































































































Director










Age










Audit




Committee










Compensation




Committee










Nominating and Corporate Governance




Committee





George K. Broady










81






































Yiu T. Chan










53










M










C










M





Kin Y. Chung










80










M










M










M





Randall A. Mason










61










C





















C





Chris T. Sharng










56












































M = Member




C = Chair









Who is the Chairman of the Board of Directors?








Mr. Mason has served as Chairman of the Board of Directors since March 2006. The Chairman of the Board of Directors organizes the work of the Board of Directors and ensures that the Board of Directors has access to sufficient information to enable the Board of Directors to carry out its functions, including monitoring the Company’s performance and the performance of management. In carrying out this role, the Chairman, among other things, presides over all meetings of the Board of Directors, establishes the annual agenda of the Board of Directors, established the agendas of each meeting in consultation with the President, and oversees the distribution of information to directors.









Which directors are considered independent?








The Board of Directors has adopted the requirements in Nasdaq Marketplace Rule 5605(a)(2) as its standard in determining the “independence” of members of its Board of Directors. The Board of Directors has determined that each of the following individuals who are nominated for election as a director qualifies as an “independent director” under this standard:








Yiu T. Chan




Kin Y. Chung




Randall A. Mason








Subject to applicable exemptions, the Company applies the foregoing Nasdaq standard for determining the “independence” of each member of its Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee. The Board of Directors has determined that all of the members of each such Committee qualifies as “independent.” Further, the Board of Directors has separately determined that each member of the Audit Committee meets the criteria for independence set forth in Rule 10A-3(b)(1) promulgated under the Exchange Act, as required for service on the Audit Committee.















5




















How often did the Board of Directors meet during fiscal 2019?








The Board of Directors met or acted by unanimous written consent a total of 14 times during the fiscal year ended December 31, 2019, and each director attended at least seventy-five percent (75%) of these meetings. As described below, the Company’s Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee each met or acted by unanimous written consent a number of times during the fiscal year ended December 31, 2019. During such fiscal year, a special committee of the Board of Directors comprised solely of the Company’s independent directors met seven times; this special committee has since been dissolved.









What is the role of the Board of Directors’ Audit, Compensation, and Nominating and Corporate Governance Committees?








Audit Committee.


Mr. Mason serves as Chairman of the Audit Committee, and Messrs. Chan and Chung also serve as members of the Audit Committee. The Board of Directors has determined that each of Messrs. Mason, Chan and Chung is independent and satisfies the other criteria set forth in the Nasdaq Marketplace Rules for service on the Audit Committee. The Board of Directors has also determined that each of Messrs. Mason and Chan meets the Securities and Exchange Commission criteria of an “audit committee financial expert” and that each also meets the requirements of Nasdaq Marketplace Rule 5605 relating to financial oversight responsibility. The Audit Committee is required to meet in person or telephonically at least four times a year. The Audit Committee met or acted by unanimous written consent a total of seven times during the fiscal year ended December 31, 2019.








The functions of the Audit Committee are set forth in the Audit Committee Charter as approved by the Board of Directors and as posted on our website at


www.naturalhealthtrendscorp.com


. In general, these responsibilities include meeting with the internal financial staff of the Company and the independent registered public accounting firm engaged by the Company to review (i) the scope and findings of the annual audit, (ii) quarterly financial statements, (iii) accounting policies and procedures and (iv) the internal controls employed by the Company. The Audit Committee is also directly and solely responsible for the appointment, retention, compensation, oversight and termination of the Company’s independent registered public accounting firm. The Audit Committee’s findings and recommendations are reported to management and the Board of Directors for appropriate action.








Compensation Committee.


The Compensation Committee operates pursuant to a charter approved by the Board of Directors, a copy of which is posted on our website at


www.naturalhealthtrendscorp.com


. The members of our Compensation Committee are Yiu T. Chan and Kin Y. Chung, with Mr. Chan serving as Chairman of the Compensation Committee. Each of the members of the Compensation Committee qualifies as an “independent director” within the meaning of the Nasdaq Marketplace Rules. The Compensation Committee is charged with responsibility to oversee our compensation policies and programs, including developing compensation, providing oversight of the implementation of the policies, and specifically addressing the compensation of our executive officers and directors, including the negotiation of employment agreements with executive officers. The Compensation Committee is not authorized to delegate to another



The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever NATURAL HEALTH TRENDS CORP makes a similar move, sign up!

Auto Refresh

Feedback